News

Net loss of Welcure Drugs & Pharmaceuticals reported to Rs 49.86 crore in the quarter ended March 2026 as against net profit of Rs 2.54 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 21.21 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 5.49 crore in the year ended March 2026 as against net profit of Rs 2.17 crore during the previous year ended March 2025. Sales rose 1388.96% to Rs 365.54 crore in the year ended March 2026 as against Rs 24.55 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales021.21 -100 365.5424.55 1389 OPM %03.02 --1.903.58 - PBDT-49.862.55 PL -5.472.79 PL PBT-49.862.54 PL -5.492.78 PL NP-49.862.54 PL -5.492.17 PL Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 December 2025.Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27 November 2025.Powered by Capital Market - Live News